ApplyBlast uses AI to match you with the right jobs, tailor your resume and cover letter, and apply automatically so you can land your dream job faster.

Features

Auto Apply Resume Optimizer Cover Letter Optimizer Interview Prep

Company

Social Media

Need Help?

team@applyblast.com

Senior Scientist at Serán BioScience - ApplyBlast

Senior Scientist

Serán BioScience

6 months ago

3.8 on Glassdoor

Bend, Oregon, United States

Onsite

Full Time

Senior

0 applicants

View Job Listing

Apply to 100+ jobs

About this role

Serán is seeking a Senior Scientist to join the Analytical Sciences group, focusing on analytical characterization and method development for novel pharmaceutical drug products. The role leads technical efforts in the laboratory, designs experiments, interprets complex data, and drives analytical strategies across development programs while collaborating with internal and external partners.

Responsibilities

Develop and validate analytical methods for pharmaceutical products
Lead cross‑functional project teams as analytical lead
Interpret data and author technical reports

Skills

Qualifications

B.S. in Chemistry, Analytical Chemistry, Chemical Engineering, Pharmaceutical Sciences, or related disciplineM.S. in Chemistry, Analytical Chemistry, Chemical Engineering, Pharmaceutical Sciences, or related disciplinePh.D. in Chemistry, Analytical Chemistry, Chemical Engineering, Pharmaceutical Sciences, or related discipline

About Serán BioScience

seranbio.com

Headquarters

Bend, Oregon, United States

Company Size

201-500 employees

Founded

2016

View Profile

Serán Bioscience is a science-driven drug development company that uses a research-first approach and advanced drug‑delivery technologies to enable and enhance clients’ medicines. They partner with biotech and pharmaceutical teams to translate therapies from concept toward clinical readiness, focusing on formulation and delivery solutions that improve patient outcomes. Headquartered in Bend, Oregon, Serán emphasizes rigorous science and collaborative development to accelerate programs and de‑risk therapeutic candidates.